Profile data is unavailable for this security.
About the company
Stemtech Corporation is a global network marketing company developing science-based wellness products focused on supporting healthy stem cell physiology. As the Stem Cell Nutrition Company, it specializes in stem cell science, offering products that enhance the function of the body’s natural stem cells. These products are designed to aid in the release, circulation, and migration of adult stem cells to tissues for optimal renewal and health. The Company markets its products internationally through subsidiaries and a network of independent distributors. Its product brands include RCM System, stemrelease3, Stemflo, MigraStem, OraStem, Cellect One Rapid Renew Stem Cell Peptide Night Cream, Cellect One Shield HOCL (Hypochlorous Acid Skin Care), and StemPets (Nutritional supplement for dogs and cats). Its OraStem Toothpaste is a multi-functional, stem cell-attracting toothpaste that also whitens teeth, freshens breath, and promotes gum health.
- Revenue in USD (TTM)3.73m
- Net income in USD-2.95m
- Incorporated2009
- Employees45.00
- LocationStemtech Corp4851 Tamiami Trail North, Suite 200NAPLES 34103United StatesUSA
- Phone+1 (954) 715-6000
- Fax+1 (954) 715-3333
- Websitehttps://www.stemtech.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stemtech Corp | 3.73m | -2.95m | 92.79k | 45.00 | -- | -- | -- | 0.0249 | -0.0227 | -0.0227 | 0.0275 | -0.0365 | 1.01 | 3.47 | 12.80 | -- | -80.17 | -- | -- | -- | 80.38 | -- | -79.43 | -- | 0.0764 | -1.32 | -- | -- | 2.69 | -- | 30.58 | -- | -- | -- |
| Nxgen Brands Inc | -100.00bn | -100.00bn | 115.88k | -- | -- | -- | -- | -- | -- | -- | -- | -0.0195 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0681 | -- | -- | -- | -62.57 | -- | 80.39 | -- | -- | -- |
| Neutra Corp | 66.08k | -177.83k | 304.29k | -- | -- | -- | -- | 4.60 | -0.00006 | -0.00006 | 0.00002 | -0.0003 | 2.42 | -- | -- | -- | -652.23 | -401.90 | -- | -- | 64.32 | -- | -269.11 | -1,234.68 | -- | -38.69 | -- | -- | -41.87 | -- | 59.53 | -- | -- | -- |
